Vertebroplasty And Kyphoplasty Devices Market

Vertebroplasty And Kyphoplasty Devices Market Overview (2022 to 2032)

The vertebroplasty and kyphoplasty devices market is expected to record a CAGR of 4.4% during the forecast period.

Attributes	Details
Vertebroplasty and Kyphoplasty Devices Market CAGR	4.4%
Vertebroplasty and Kyphoplasty Devices Market (2018)	USD 1 Billion

Sales of vertebroplasty and kyphoplasty devices are expected to rise as they are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF).

Back pain, depression, loss of independence, decreased lung capacity, and difficulty sleeping can all result from VCFs. Hence, treating the same carries importance which surges the demand for vertebroplasty and kyphoplasty devices.

In addition, the higher sales of vertebroplasty and kyphoplasty devices can be attributed to the help that it provides to the patient to regain functional abilities and avoid further vertebral collapse.

Demand for vertebroplasty and kyphoplasty devices spikes as kyphoplasty is an advanced version of vertebroplasty that can stabilize the fracture, restore heights and reduce deformities.

The syringe can be used to inject cement as well as inflate and deflate interventional devices. As a result, these factors are expected to increase the demand for vertebroplasty and kyphoplasty devices.

Due to people's changing lifestyles, the sales of vertebroplasty and kyphoplasty devices are expected to grow significantly.

Furthermore, an increase in demand for minimally invasive spine surgery procedures propels the demand for vertebroplasty and kyphoplasty devices and in turn, the sales of vertebroplasty and kyphoplasty devices.

The demand for vertebroplasty and kyphoplasty devices is being driven by an ageing population, which has resulted in an increase in the number of vertebral compression fractures and an increase in health-care expenditure.

Although specialty antibody applications are specifically used in research and diagnostic procedures, hospitals are a major end-user and the same facilitates the high demand for vertebroplasty and kyphoplasty devices.

The rising sales of vertebroplasty and kyphoplasty devices is also due to the improved hospital infrastructure in the United States, Europe, and other developed countries is strong.

Who are Some of the Major Players in the Vertebroplasty and Kyphoplasty Devices Market?

Demand for vertebroplasty and kyphoplasty devices is growing due to limitations in the traditional techniques for the treatment of vertebral compression fractures.

Vertebroplasty and kyphoplasty are advanced procedure which result in pain relief, stabilization of the fracture and avoid “Downward spiral” of untreated osteoporosis thereby spikes the sales of vertebroplasty and kyphoplasty devices.

Due to increase in ageing population, patients suffering from osteoporosis are also increasing the sales of vertebroplasty and kyphoplasty devices.

The rising demand for vertebroplasty and kyphoplasty devices can be contributed to benefit of the surgery such as short surgical time where patient gets discharged in less than one day.

Sales of vertebroplasty and kyphoplasty devices grow as surgery involves requirement of general anaesthesia and non-requirement of bracing.

Complications like bleeding, infection post-surgery and chances of occurrence of another fracture are few restraints for the demand for vertebroplasty and kyphoplasty devices.

VCF is a major issue in the western countries driving the demand for vertebroplasty and kyphoplasty devices and in turn, sales of vertebroplasty and kyphoplasty devices.

Overall sales of vertebroplasty and kyphoplasty devices will grow globally, however the growth rate in Asia Pacific region will be more as compared to European and North American market.

Why is North America at the Forefront of the Vertebroplasty and Kyphoplasty Devices Market?

Depending on geographic regions, the global vertebroplasty and kyphoplasty devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America is the holding a major porting of the vertebroplasty and kyphoplasty devices market share due to the high volumes of surgical procedures being performed.

Also, the availability of established healthcare infrastructure, high contribution of healthcare to economy, patient compliance are the reasons for the high vertebroplasty and kyphoplasty devices market share of North America.

North America’s vertebroplasty and kyphoplasty devices market share can also be credited to the high prices of the kyphoplasty procedure in the United States, as well as the country's high incidence rate of vertebral compression fractures.

Europe has the second largest vertebroplasty and kyphoplasty devices market share due to vast technological advancement in terms of healthcare sector.

Asia Pacific market is expected to witness a good vertebroplasty and kyphoplasty devices market growth rate as compared to North America and Europe as there is ample market opportunity in countries like India and China.

Who are the Key Players in the Vertebroplasty and Kyphoplasty Devices Market?

Some of the key market players in global vertebroplasty and kyphoplasty devices market are Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd.

In terms of vertebroplasty and kyphoplasty devices market share, a few major players currently dominate the market.

Companies have been launching strategic initiatives to expand their presence in the market under consideration.

• Medtronic acquired Titan Spine to expand its spinal surgery product portfolio.
• Stryker's AVAflex balloon system for treating vertebral compression fractures has been approved by the FDA. This technology was purchased by the company from BD.

Report Attributes	Details
Growth rate	CAGR of 4.4% from 2022 to 2032
Base year for estimation	2021
Historical data	2015 to 2020
Forecast period	2022 to 2032
Quantitative units	Revenue in USD million, volume in kilotons, and CAGR from 2022 to 2032
Report coverage	Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments covered	Product, Region
Regional scope	North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand
Country scope	USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa
Key companies profiled	Depuy Synthes; Stryker Corporation; CareFusion Corporation; Osseon LLC.; Alphatec Spine, Inc.; TAEYEON MEDICAL Co., Ltd.; G-21 s.r.l.; BMK Global Medical Company; Medtronic, Inc.; Globus Medical, Inc. and SOMATEX.
Customization scope	Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.?

Key Segments

By Product:

• Vertebroplasty Devices
• Kyphoplasty Devices

By Region:

• North America
• Latin America
• Asia Pacific
• MEA
• Europe

Frequently Asked Questions

What is the Growth Outlook of the Vertebroplasty and Kyphoplasty Devices Market?

The vertebroplasty and kyphoplasty devices market likely registers a CAGR of 4.4% during the forecast period.

Which Region has the Highest Growth Rate in the Vertebroplasty and Kyphoplasty Devices Market?

Asia Pacific is expanding at the fastest rate owing to broad vertebroplasty and kyphoplasty devices market opportunities.

Who are the Key Players in the Vertebroplasty and Kyphoplasty Devices Market?

Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd. are some of the key players in the vertebroplasty and kyphoplasty devices market.